Support IAC Cancer Warrior Brayden
Our amazing Cancer Warrior Brayden is fighting for his life. He was diagnosed on 09/07/20 with a brain tumor. According to Braintumor.org, today there is an estimated 700,000 people in the United States who are living with a primary brain tumor, and over 87,000 more will be diagnosed in 2020. Brain tumors can be deadly, significantly impact quality of life, and change everything for a patient and their loved ones. They do not discriminate, inflicting men, women, and children of all races and ethnicities. The website goes on to list some very helpful information.
Helpful Brain Tumor Facts:
An estimated 700,000 Americans are living with a brain tumor
69.8% tumors are benign
30.2% tumors are malignant
An estimated 87,240 people will receive a primary brain tumor diagnosis in 2020
61,430 will be benign
Meningiomas are the most commonly occurring primary non-malignant brain tumors (accounting for 37.6% of all tumors, and 53.3% of all non-malignant tumors).
Approximately 36% of the non-malignant tumors occur in males, and 64% in females
25,800 will be malignant
Glioblastoma is the most commonly occurring primary malignant brain tumor (accounting for 14.6% of all tumors, and 48.3% of all malignant tumors)
Approximately 55.4% of the malignant tumors occur in males, and 44.6% in females
The average survival rate for all malignant brain tumor patients is only 36%
Survival rates vary by age and tumor type, generally decreasing with age
For non-malignant brain tumor patients, the average five-year survival rate in 91.5%, with pilocytic astrocytomas the highest at 94.4%
For the most common form of primary malignant brain tumors, glioblastoma, the five-year relative survival rate is only 6.8%
An estimated 18,020 people will die from malignant brain tumors (brain cancer) in 2020
BRAIN TUMORS IN CHILDREN (0-14)
3,657 children are estimated to be living with a brain tumor in the U.S.
Approximately 4.3% of all brain tumor cases diagnosed each year occur in children ages 0-14
An estimated 3,540 new cases of childhood brain tumors are expected to be diagnosed in 2020
Brain tumors are the most common solid cancer in persons age 0-14 years, as well as when expanded to ages 0-19 years
The average survival rate for all malignant pediatric brain tumors is 74.7%
Pediatric brain tumors are the leading cause of cancer-related death among children and adolescents ages 0-14 years, as well when expanded to ages 0-19 years, surpassing leukemia
The most prevalent brain tumor types in children (0-14):
Gliomas, including ependymal tumors, pilocytic astrocytomas, and diffuse intrinsic pontine gliomas
Embroyonal tumors, including medulloblastoma and AT/RT
BRAIN TUMORS IN YOUNG ADULTS (15-39)
Approximately 14.7% of all brain tumors occur in the AYA population
An estimated 12,090 new cases of AYA brain tumors will be diagnosed in 2020
AYA brain tumor patients have higher five-year relative survival rates than adults (40+), but lower rates than children (0-14)
Brain tumors are the third-most common cancer overall in individuals age 15-39 years, and the second-most common cancer in males and third-most common in females in this age group
Among adolescents only (15-19), brain tumors are the most common form of cancer, accounting for 21% of diagnoses in this age group each year
Brain tumors are the third leading cause of cancer-related death overall in this age group
Brain tumors are the leading cause of cancer-related death in males aged 20-39 and the fourth leading cause of cancer-related death in females in this age group
The most common brain tumors in the AYA population are: pituitary tumors, meningiomas, and nerve sheath tumors
Furthermore
The site goes on to explain that more than any other cancer, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life. Malignant brain tumors cause an average of 20 Years of Potential Life Lost (YPLL) for individuals diagnosed as adults, which exceeds most common cancers. Among children ages 0-19 years, brain tumors represent the largest cause of YPLL due to cancer, with a mean YPLL of approximately 80 years.
The incidence rates for brain tumors are highest among individuals ages 85+, and lowest among children and adolescents ages 0-19 years.
Despite the number of brain tumors, and their devastating prognosis, there are only five FDA approved drugs – and one device – to treat brain tumors. For many tumor types, surgery and radiation remain the standard of care.
There has never been a drug developed and approved specifically for malignant pediatric brain tumors.
The five approved drugs for brain tumors have provided only incremental improvements to patient survival, and mortality rates remain little changed over the past 30 years.
Brain tumors represent the highest per-patient initial cost of care for any cancer group, with an annualized mean net cost of care approaching $150,000; and the highest annualized mean net costs for last-year-of-life care, relative to other cancers, at $135,000 to $210,000 (depending on age and gender) per patient. [J Natl Cancer Inst. 2011 Jan 19; 103(2): 117–128.]
**Statistics sourced from the Central Brain Tumor Registry of the United States (CBTRUS) in CBTRUS Statistical Facts Report of Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States (www.cbtrus.org, unless otherwise noted.) You can view all the info on BrainTumer.org’s website as well.
How to Show Support for Cancer Warrior Brayden
Any little help will make a difference to help his family with medical bills @inkagainstcancer @iaccancerwarriorsfoundation
You can show support by sending your donation to:
Venmo: Iac-cancerwarriorsfoundation
PayPal: https://www.paypal.me/iaccancerwarriors
CashApp: $iaccancerwarriorsfdn
